- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- N-14 Registration statement for investment companies business combination
- 99 Management Contract Between Fidelity Disruptive Automation Etf
- 99 Management Contract Between Fidelity Disruptive Communications Etf
- 99 Management Contract Between Fidelity Disruptive Finance Etf
- 99 Management Contract Between Fidelity Disruptive Medicine Etf
- 99 Management Contract Between Fidelity Disruptive Technology Etf
- 99 Management Contract Between Fidelity Disruptors Etf
- 99 General Distribution Agreement Filed Herein As Exhibit (7)(7)
- 99 General Distribution Agreement Filed Herein As Exhibit (7)(8)
- 99 General Distribution Agreement Filed Herein As Exhibit (7)(9)
- 99 General Distribution Agreement Filed Herein As Exhibit (7)(10)
- 99 General Distribution Agreement Filed Herein As Exhibit (7)(11)
- 99 General Distribution Agreement Filed Herein As Exhibit (7)(12)
- 99 Distribution and Service Plan Pursuant Is Filed Herein As Exhibit (10)(7)
- 99 Distribution and Service Plan Pursuant Is Filed Herein As Exhibit (10)(8)
- 99 Distribution and Service Plan Pursuant Is Filed Herein As Exhibit (10)(9)
- 99 Distribution and Service Plan Pursuant Is Filed Herein As Exhibit (10)(10)
- 99 Distribution and Service Plan Pursuant Is Filed Herein As Exhibit (10)(11)
- 99 Distribution and Service Plan Pursuant Is Filed Herein As Exhibit (10)(12)
- 99 Opinion and Consent of Counsel Dechert LLP, As to the Legality of Shares
- 99 Consent of Pricewaterhousecoopers LLP, Dated January 20, 2023
- 99 Consent of Deloitte and Touche LLP, Dated January 20, 2023
- 99 Power of Attorney, Dated December 1, 2022
- 6 Jul 23 POS EX Additional exhibits for listing
-
20 Jan 23 N-14 Registration statement for investment companies business combination
Exhibit (14)(1)
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form N-14 of Fidelity Covington Trust of our report dated July 15, 2022, relating to the financial statements and financial highlights, which appears in Fidelity Disruptive Automation Fund, Fidelity Disruptive Communications Fund, Fidelity Disruptive Finance Fund, Fidelity Disruptive Medicine Fund and Fidelity Disruptive Technology Fund’s Annual Reports on Form N-CSR for the year ended May 31, 2022. We also consent to the references to us under the headings “Additional Information About the Funds” and “Experts” in such Registration Statement and to the references to us under the headings “Financial Highlights” in the Prospectuses and “Independent Registered Public Accounting Firms” in the Statements of Additional Information dated July 30, 2022 for Fidelity Disruptive Automation Fund, Fidelity Disruptive Communications Fund, Fidelity Disruptive Finance Fund, Fidelity Disruptive Medicine Fund and Fidelity Disruptive Technology Fund, which are also incorporated by reference in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
January 20, 2023